McCarron D A, Muther R S, Plant S B, Krutzik S
Am J Kidney Dis. 1981 Jul;1(1):38-44. doi: 10.1016/s0272-6386(81)80009-1.
Persistent hyperparathyroidism and its attendant hypercalcemia have been implicates as possible etiologic factors in posttransplant hypertension. To better define the role of parathyroid hormone (PTH) and calcium in posttransplant blood pressure homeostasis, we measured the acute response of blood pressure, ionized calcium (Ca++), plasma renin activity (PRA), and parathyroid hormone (PTH) to a 4-hr infusion of calcium (15 mg/kg) and an isoproterenol injection (0.15 mg SC) in seven normal subjects and 13 renal transplant (Tx) recipients with stable graft function and persistent hyperparathyroidism. Transient hypercalcemia produced a significant (p less than 0.01) increase in the systolic blood pressure (delta SBP) and suppression of PTH (p less than 0.001) in the posttransplant subjects. There was a significant (p less than 0.02) inverse correlation between changes (delta) in PTH and delta SBP in these subjects. There was no correlation between the delta SBP and either the change in Ca++ (delta Ca++) or the change in PRA (delta PRA) observed in the Tx recipients administered calcium. Following isoproterenol administration, SBP increased (p less than 0.01), PTH fell (p less than 0.05) and Ca++ was only minimally increased in the Tx recipients. A virtually identical, significant (p less than 0.05) inverse correlation existed between the delta PTH and delta SBP observed in the transplant subjects. Greater suppression of PTH was associated with a larger increase in systolic blood pressure. Transient hypercalcemia of comparable degree in normal subjects caused an insignificant increase in their blood pressure. The fact that PTH suppression in the normals was substantially (0.01) less (delta PTH -13 microliter/Eq/ml versus -65 microliter/Eq/ml in the transplant group) with a similar increase in serum calcium suggests that the blood pressure response to transient hypercalcemia is more dependent on PTH suppression than the level of ionized calcium. Plasma renin activity was unchanged during the blood pressure fluctuations induced by either the calcium or the isoproterenol administration to the normal subjects. Under the conditions of this study, endogenous parathyroid hormone has the characteristics of a vasodepressor hormone and may have a role in blood pressure regulation in transplant recipients with hyperparathyroidism. Since the vasodepressor effect can be dissociated from delta Ca+ and delta PRA, such a conclusion seems warranted. The implications of these findings for all subjects with renal disease requires further investigation.
持续性甲状旁腺功能亢进及其伴随的高钙血症被认为可能是移植后高血压的病因。为了更好地确定甲状旁腺激素(PTH)和钙在移植后血压稳态中的作用,我们测量了7名正常受试者和13名移植肾功能稳定且持续性甲状旁腺功能亢进的肾移植(Tx)受者在输注钙(15mg/kg)4小时和皮下注射异丙肾上腺素(0.15mg)后血压、离子钙(Ca++)、血浆肾素活性(PRA)和甲状旁腺激素(PTH)的急性反应。短暂性高钙血症使移植后受试者的收缩压(ΔSBP)显著升高(p<0.01),并抑制了PTH(p<0.001)。这些受试者中,PTH的变化(Δ)与ΔSBP之间存在显著的负相关(p<0.02)。在接受钙治疗的Tx受者中,ΔSBP与Ca++的变化(ΔCa++)或PRA的变化(ΔPRA)之间均无相关性。给予异丙肾上腺素后,Tx受者的SBP升高(p<0.01),PTH下降(p<0.05),Ca++仅略有升高。在移植受试者中观察到,ΔPTH与ΔSBP之间存在几乎相同的显著负相关(p<0.05)。PTH抑制程度越大,收缩压升高幅度越大。正常受试者中程度相当的短暂性高钙血症使其血压升高不显著。正常受试者中PTH抑制程度明显较小(0.01)(ΔPTH为-13微升/当量/毫升,而移植组为-65微升/当量/毫升),而血清钙有类似升高,这表明对短暂性高钙血症的血压反应更多地依赖于PTH抑制,而非离子钙水平。在正常受试者中,钙或异丙肾上腺素诱导血压波动期间,血浆肾素活性未发生变化。在本研究条件下,内源性甲状旁腺激素具有血管降压激素的特征,可能在甲状旁腺功能亢进的移植受者的血压调节中起作用。由于血管降压作用可与ΔCa+和ΔPRA分离,这一结论似乎是合理的。这些发现对所有肾病患者的影响需要进一步研究。